Overview: This page contains the latest trade data of Vaccines, human use. In 2019, Vaccines, human use were the world's 72nd most traded product, with a total trade of $32.7B. Between 2018 and 2019 the exports of Vaccines, human use grew by 6.45%, from $30.7B to $32.7B. Trade in Vaccines, human use represent 0.18% of total world trade.
Exports: In 2019 the top exporters of Vaccines, human use were Belgium ($9.06B), Ireland ($7.57B), France ($4.52B), United Kingdom ($2.83B), and United States ($2.23B).
Imports: In 2019 the top importers of Vaccines, human use were United States ($8.85B), Belgium ($6.76B), United Kingdom ($2.16B), Germany ($1.58B), and China ($858M).
Tariffs: In 2018 the average tariff for Vaccines, human use was 0.81%, making it the 6386th lowest tariff using the HS6 product classification.
The countries with the highest import tariffs for Vaccines, human use are India (8.18%), Aruba (6%), Pakistan (5.57%), Mongolia (4.98%), and Chad (4.9%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Algeria (0%), Egypt (0%), and Ethiopia (0%).
Ranking: Vaccines, human use ranks 735th in the Product Complexity Index (PCI).
Description: A vaccine is a substance that creates immunity against a disease. It is typically administered by injection, but may be administered orally or by aerosol. Vaccines can protect against many infectious diseases including measles, mumps, tetanus, polio, rubella, and hepatitis A.